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Abstract 
Background: Subpatent malaria infections, or low-density infections below the detection threshold of microscopy 
or standard rapid diagnostic testing (RDT), can perpetuate persistent transmission and, therefore, may be a barrier 
for countries like Namibia that are pursuing malaria elimination. This potential burden in Namibia has not been well 
characterized.
Methods: Using a two-stage cluster sampling, cross-sectional design, subjects of all age were enrolled during the 
end of the 2015 malaria transmission season in Zambezi region, located in northeast Namibia. Malaria RDTs were per-
formed with subsequent gold standard testing by loop-mediated isothermal amplification (LAMP) using dried blood 
spots. Infection prevalence was measured and the diagnostic accuracy of RDT calculated. Relationships between 
recent fever, demographics, epidemiological factors, and infection were assessed.
Results: Prevalence of Plasmodium falciparum malaria infection was low: 0.8% (16/1919) by RDT and 2.2% (43/1919) 
by LAMP. All but one LAMP-positive infection was RDT-negative. Using LAMP as gold standard, the sensitivity and 
specificity of RDT were 2.3% and 99.2%, respectively. Compared to LAMP-negative infections, a higher portion 
LAMP-positive infections were associated with fever (45.2% vs. 30.4%, p = 0.04), though 55% of infections were not 
associated with fever. Agricultural occupations and cattle herding were significantly associated with LAMP-detectable 
infection (Adjusted ORs 5.02, 95% CI 1.77–14.23, and 11.82, 95% CI 1.06–131.81, respectively), while gender, travel, bed 
net use, and indoor residual spray coverage were not.
Conclusions: This study presents results from the first large-scale malaria cross-sectional survey from Namibia using 
molecular testing to characterize subpatent infections. Findings suggest that fever history and standard RDTs are 
not useful to address this burden. Achievement of malaria elimination may require active case detection using more 
sensitive point-of-care diagnostics or presumptive treatment and targeted to high-risk groups.
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diagnostic test, RDT, Namibia
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Background
Subpatent malaria infections, or low-density malaria 
infections below the detection threshold of standard 
rapid diagnostic tests (RDT) or microscopy, may be 
responsible for at least 20–50% of malaria transmission in 
pre-elimination and elimination settings [1–4]. As such, 
they are a key target for countries aiming to reduce or 
interrupt transmission [5]. These infections have gener-
ally been considered asymptomatic or minimally sympto-
matic, but there is also increasing data to suggest they are 
associated with adverse health effects including recurrent 
episodes of symptomatic parasitaemia, chronic anaemia, 
maternal and neonatal mortality, co-infection with inva-
sive bacterial disease, and cognitive impairment [6].
A better understanding of the prevalence and char-
acteristics of subpatent infections can inform the 
design of targeted strategies for malaria elimination 
[7–9]. Namibia is a low transmission country in south-
ern Africa that has experienced a tremendous decline 
in reported malaria cases over the past decade due 
to the successful implementation of malaria control 
interventions. The country is now aiming to eliminate 
malaria [10], but the burden of subpatent infections has 
not been well-characterized [11, 12]. To address this 
gap, a large household-based cross-sectional survey 
was conducted in Zambezi region, Namibia. The study 
aimed to: (1) measure the prevalence of subpatent 
infection using loop-mediated isothermal amplification 
(LAMP), a molecular detection method, (2) measure 
the diagnostic accuracy of standard RDT using LAMP 
as gold standard, and (3) identify potential risk factors 
for subpatent malaria infection.
Methods
Study setting
Zambezi region is located in the northern malarious area 
of Namibia, and shares borders with the higher malaria 
endemic countries of Angola and Zambia (Fig.  1a). It 
is a primarily rural setting with most of the population 
engaged in subsistence farming. From 2004 to 2015, the 
annual parasite incidence in Zambezi fell from over 600 
to 17.1 cases per 1000 in 2014 [12, 13]. This decline in 
Fig. 1 a Map of Zambezi region and study area, b spatial distribution of study participants and rapid diagnostic test (RDT) and loop-mediated 
isothermal amplification (LAMP) detected infections. RDT rapid diagnostic test, DBS dried blood spot, LAMP loop-mediated isothermal amplification
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incidence occurred in the setting of improved implemen-
tation of indoor residual spraying (IRS), distribution and 
use of long-lasting insecticide-treated bed nets (ITNs), 
increased RDT use, and treatment of confirmed cases 
with artemisinin-based combination therapy. With high 
temperatures and significant seasonal rainfall, Zambezi 
region is the wettest region in Namibia. Following the 
wet season of October to May, the high transmission sea-
son typically begins in November, peaks between January 
and April, and then trails off in May. Reported malaria 
cases are almost all due to Plasmodium falciparum and 
the most common malaria vector species is Anopheles 
arabiensis [14].
Study design and sample size
This cross-sectional survey was carried out at the end 
of the transmission season from April to June 2015 in 
the historically higher burden western part of Zambezi 
region (Fig.  1a), where based on the 2011 census data 
and projected growth rate, the estimated population size 
of the study area in 2015 was 35,381 [15]. In early 2015, 
the households in the study area were mapped and health 
facility catchment areas were defined, providing a house-
hold sampling frame for this survey. A two-stage, cluster 
sampling design was employed, where six of the eleven 
health facilities within the study area were randomly 
selected. Households from the selected health facility 
catchment areas were then randomly selected for inclu-
sion in the survey.
The total target sample size was 2000 participants 
to detect a 5% prevalence based on LAMP with 80% 
study power and 5% significance level. These calcula-
tions assumed a 10% refusal rate, design effect of two (to 
account for correlations between clusters at the health 
facility level), annual parasite incidence (API) of at least 
15/1000, 40% probability of clinical symptoms, 51% prob-
ability of seeing care at a health facility if febrile, 85% 
RDT diagnostic sensitivity for symptomatic infections, 
and 50% prevalence of annual incidence infections dur-
ing the survey [16, 17]. Assuming an average of six indi-
viduals per household and that 10% of households would 
not be enrolled, 540 households was determined to be 
sufficient to reach the target sample size. However, 23% 
of households could not be enrolled due to absence or 
having moved away. Toward the end of the survey, an 
additional 144 households were randomly selected for 
recruitment.
Participants
All individuals in selected households were eligible for 
inclusion in the survey if they were usual residents of the 
household or had slept in the household the night before. 
A complete line listing of all eligible individuals was gen-
erated at the first visit and subjects were excluded if they 
refused to participate, were too ill to participate, or were 
not present at any of three visits to each household.
Data collection
Selected households were approached for written 
informed consent, which was conducted at the indi-
vidual level and from a parent or guardian for minors 
less than 18 years of age. Additionally, minor assent was 
obtained for children > 12  years of age. Blood was col-
lected by finger prick from all consenting participants 
for malaria testing by  Carestart™ Malaria HRP2/pLDH 
(Pf/PAN) RDT (AccessBio, Somerset, NJ) and to gener-
ate a dried blood spot (DBS) using  Whatmann™ 3 MM 
filter paper (GE Healthcare, Chicago, IL). Presence of 
clinical symptoms was assessed by self-report of fever 
in the prior 2  weeks. Infections associated with lack of 
self-reported fever were considered subclinical. Partici-
pants were interviewed in the local language SiLozi using 
a standardized tablet-based household questionnaire 
(administered to the household head or other adult rep-
resentative) and individual questionnaire via Open Data 
Kit (ODK) software.
Household level data included the household location, 
socioeconomic status, household population, ITN own-
ership, as well as IRS coverage in the past 12  months. 
Questions assessing socioeconomic status included 
assessment of water source and household assets includ-
ing electricity, radios, televisions, mobile phones, and 
refrigerators. The individual questionnaire assessed 
demographics, travel history, vector control coverage and 
use, history of malaria, and care-seeking behaviour asso-
ciated with fever the past 2 weeks. All RDT positive indi-
viduals were considered to have uncomplicated malaria 
and received treatment in the field with artemether-
lumefantrine according to national guidelines [18]. Sub-
jects with severe malaria or illness not attributable to 
malaria were referred to the nearest health facility after 
assessment by study nurses. Up to two return visits were 
made to each household to maximize enrollment, with 
the goal to enroll at least 80% of residents within each 
household.
Laboratory methods
DBS cards were transported to the University of Namibia 
Multi-Disciplinary Research Center laboratory in Wind-
hoek. DNA was extracted using the Saponin/Chelex 
method previously described [19]. Using 15 µL of DNA 
extraction product, Plasmodium-specific testing was 
conducted using a commercial loop-mediated isothermal 
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amplification kit (PAN-LAMP Loopamp detection kit, 
Eiken Chemical, Japan) in accordance with manufac-
turer’s instructions [20]. For quality assurance, all sam-
ples that were positive by RDT and/or PAN-LAMP and 
a random sampling of 10% of samples that were negative 
by RDT and LAMP underwent further testing by nested 
PCR (nPCR) targeting the cytochrome b gene, followed 
by species identification via AluI digest for nPCR posi-
tives [21]. Five microliter of DNA extraction product 
was used for nPCR. For any LAMP/nPCR discordant 
results, nPCR was repeated two additional times; nPCR 
was considered positive if at least one of the three results 
was positive. For LAMP and nPCR positive controls with 
parasite densities of at least 1 to 5 parasites/µL and 0.1 to 
1 parasites/µL, respectively, were used.
Data management and statistical analysis
Survey data were uploaded from tablet devices to a 
secure cloud-based sever at least weekly. Data were ana-
lysed using STATA (version 14.0; STATA Corp., College 
Station, TX, USA). Locations of cases were mapped using 
QGIS (version 2.16.2). Prevalence of malaria infection by 
RDT and LAMP were estimated and compared. Diagnos-
tic accuracy of RDT was calculated using LAMP as gold 
standard. Based on the nPCR results of 10% of negative 
cases and all discordant LAMP and RDT samples, qual-
ity assurance of LAMP was assessed by calculating sen-
sitivity and specificity of LAMP using nPCR as a gold 
standard. Demographic and epidemiological character-
istics of participants were described. A housing qual-
ity variable was constructed by a principal component 
analysis based on type of wall, roof, window, and eaves. 
A socioeconomic status index was generated by prin-
cipal component analysis based on six household assets 
ownership variables, wall type, roof type, and household 
water source.
Associations between covariates and LAMP-detectable 
malaria infection were explored using Chi squared and 
Fisher’s exact tests (Table 2). Epidemiological covariates 
with a p value of less than 0.10 in this bivariate analysis 
were included in multivariate logistic regression mod-
els, with gender, age, and socioeconomic status included 
a priori. Comparisons accounted for clustering at the 
highest level [22, 23] (by health facility catchment area) 
using robust standard errors. Reported fever in the prior 
2  weeks was not included in the multivariate analysis 
due to it not being an epidemiological risk factor and 
its association with the outcome of infection. However, 
fever history was used for a stratified analysis of the diag-
nostic accuracy of RDT using LAMP as gold standard. 
Among the subset of individuals with fever history, the 
association between care-seeking behaviour and LAMP 
detectable malaria infection was also assessed separately. 
To investigate the distribution of malaria infection within 
the study area, spatial clusters of high malaria prevalence 
were identified using Kulldorff’s spatial scan statistic 
SaTScan™ v9.4 (SaTScan Boston, MA). Clustering was 
assessed using a spatial Bernoulli model (no other envi-
ronmental covariates were included) with a maximum 
radius of 5 km and statistical significance tested by like-
lihood ratio, based on 999 Monte Carlo repetitions [24].
Results
Enrollment
Of the 684 households sampled from the six catchment 
areas, 529 (77.3%) were enrolled (Fig.  2). Among 2290 
eligible individuals in enrolled households, 1919 (83.8%) 
were tested by RDT and LAMP. The most common rea-
son for lack of enrollment was that no household head 
was present after three visits by study teams. The most 
common reasons blood testing was not performed were 
absence (7.2%) and DBS not available (not collected, lost 
or insufficient blood) (6.5%).
Study population characteristics
Study population characteristics are shown in Table  1. 
A slightly higher proportion of enrollees were female 
(55.0%) than male and the largest age group enrolled 
was children 15 years old or younger (47.0%). The most 
common occupation was agriculture representing 
12.6% (241/1919) of all subjects, and 23.7% (241/1016) 
of the population over 15 years of age. Almost a quarter 
(23.1%) of the total adult population was unemployed. 
Fifteen percent of participants reported travel in the 
previous 1 to 8  weeks, with most travel being domestic 
16 (0.8%)
RDT+
529 Households enrolled (77.3%)
2290 Individuals eligible
684 Households selected
13 (1.9%) Refused
2 (0.3%) Unable to give consent
140 (20.5%) Not present
166 (7.2%) Not present
58 (2.5%) Refused blood testing
147 (6.5%) Dried blood spot not
collected, lost, or insufficient
1919 Individuals tested
by RDT and LAMP (83.8%)
43 LAMP+ (2.2%)
1861 LAMP-
1903 (99.2%)
RDT-
15 LAMP-
Fig. 2 Enrollment and malaria testing results. RDT rapid diagnostic 
test, LAMP loop-mediated isothermal amplification
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Table 1 Characteristics of study population, and association between clinical, demographic, and epidemiological factors 
and malaria infection
Total (%)
n = 1919
LAMP negative (%)
n = 1876
LAMP positive (%)
n = 42
p-value
Clinical
 Fever in the past 2 weeks
  No 1292 (69.2) 1269 (98.2) 23 (1.8) 0.04
  Yes 574 (30.8) 555 (96.7 19 (3.3)
Demographics
 Gender
  Female 1056 (55.0) 1033 (97.8) 23 (2.2) 0.84
  Male 863 (45.0) 843 (97.7) 20 (2.3)
 Age (years)
  < 15 902 (47.0) 889 (98.6) 13 (1.4) 0.07
  15–40 629 (32.8) 609 (96.8) 20 (3.2)
  > 40 387 (20.2) 378 (97.4) 10 (2.6)
 Occupationa
  Agricultural 241 (12.6) 229 (95.0) 12 (4.9) 0.001
  Fishing 25 (1.3) 24 (96.0) 1 (4.0)
  Cattle herder 27 (1.4) 24 (88.9) 3 (11.1)
  Other manual labour 51 (2.7) 49 (96.1) 2 (3.9)
  Police officer/guard 16 (0.8) 16 (100) 0 (0)
  Office/commercial/professional 28 (1.5) 27 (96.4) 1 (3.6)
  Small market sales 27 (1.4) 27 (100) 0 (0)
  Unemployed/homemaker/retiree 443 (23.1) 438 (98.9) 5 (1.1)
  Student 146 (7.6) 142 (97.3) 4 (2.7)
  Otherb 13 (0.7) 11 (84.6) 2 (15.4)
  ≤ 15 years old 902 (47.0) 889 (98.6) 13 (1.4)
 Socio-economic status
  Lowest 368 (19.7) 360 (97.8) 8 (2.2) 0.99
  Lower-middle 353 (18.9) 345 (97.7) 8 (2.3)
  Middle 380 (20.3) 372 (97.9) 8 (2.1)
  Upper-middle 384 (20.6) 376 (97.9) 8 (2.1)
  Highest 384 (20.6) 374 (97.4) 10 (2.6)
Residence
 Health facility catchment area
  Chinchimane 179 (9.3) 174 (97.2) 5 (2.8) 0.83
  Choi 308 (16.1) 300 (97.4) 8 (2.6)
  Kanono 226 (11.9) 221 (97.8) 5 (2.2)
  Kasheshe 340 (17.7) 331 (97.4) 9 (2.6)
  Sesheke 462 (24.1) 455 (98.5) 7 (1.5)
  Sibbinda 403 (21.0) 394 (97.8) 9 (2.2)
Travel
 Travel in past 8 weeks
  No 1597 (85.5) 1560 (97.7) 37 (2.2) 0.17
  Yes 270 (14.5) 263 (97.4) 7 (2.4)
 Travel categories
  No travel 1597 (85.5) 1562 (97.8) 35 (2.2) 0.76
  Domestic travel 256 (13.7) 249 (97.3) 7 (2.1)
  International travel 16 (0.9) 16 (100) 0 (0)
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(94.1%) rather than international (5.9%). Fever in the last 
2 weeks was reported by 30.8% of participants. Overall, 
33.1% of participants reported using an ITN the previous 
night and 59.6% of individuals lived in a household that 
received IRS in the past 12 months.
Prevalence of malaria infection
The overall prevalence of Plasmodium infection 
detected by RDT was 0.8%, 95% CI 0.4% to 1.2% 
(16/1919). By LAMP, prevalence was 2.2%, 95% CI 1.6% 
to 2.9% (43/1919) and in subsequent nPCR testing, all 
LAMP-positive infections were identified as P. falci-
parum mono-infection. Malaria prevalence by health 
facility catchment area ranged from 0 and 1.7% by RDT 
and 1.5 to 2.8% by LAMP. There were no statistically 
significant differences in malaria prevalence by health 
facility catchment area (χ2 = 1.80, p = 0.88).
Figure 1b shows the spatial distribution of study par-
ticipants and RDT and LAMP detected infections, 
which reflects the population distribution along major 
roads. In the SatScan analysis, no statistically signifi-
cant clusters of malaria infection were observed over 
the entire study area or within health facility catchment 
areas.
Diagnostic accuracy
Compared to 2.2% infection prevalence by LAMP, preva-
lence of infection by RDT was only 0.8%. There was lit-
tle concordance between RDT and LAMP positivity, with 
only one participant positive by both detection methods. 
Of seven symptomatic individuals who were RDT posi-
tive and LAMP negative, 2 (28%) reported treatment with 
artemether–lumefantrine within the past 2 weeks. Using 
LAMP as gold standard, the diagnostic accuracy of RDT 
was assessed in the total study population and in those 
with and without fever in the previous 2 weeks (Table 2). 
The sensitivities and positive predictive values were 
extremely low in all groups and specificities and negative 
predictive values high in all groups.
Overall, the sensitivity and specificity of LAMP in the 
total study population using nPCR as the gold standard 
was 75.0% (95% CI 57.8–87.9) and specificity was 99.2% 
(95% CI 98.6–99.5), respectively. Among the samples that 
had repeat nPCR results, there were no discordant nPCR 
results. There was only one LAMP negative sample that 
was PCR positive. That all but one of the 15 RDT-posi-
tive LAMP-negative samples were confirmed negative by 
nPCR suggests that these samples were false RDT-posi-
tives (Additional file 1).
Table 1 (continued)
Total (%)
n = 1919
LAMP negative (%)
n = 1876
LAMP positive (%)
n = 42
p-value
Housing
 Tertile of housing  qualityc
  Lowest 866 (46.4) 849 (98.0) 17 (2.0) 0.74
  Middle 405 (21.7) 395 (97.5) 10 (2.5)
  Highest 594 (31.9) 579 (97.5) 15 (2.5)
 Individuals per household
  < 5 194 (10.6) 192 (99.0) 2 (1.0) 0.50
  ≥ 5 and < 10 1011 (55.1) 988 (97.7) 23 (2.3)
  ≥ 10 629 (34.3) 613 (97.5) 16 (2.5)
Vector control
 ITN ownership
  None 854 (45.6) 834 (97.7) 20 (2.3) 0.88
  < 1 ITN per 2 people 647 (34.6) 634 (98.0) 13 (2.0)
  ≥ 1 ITN per 2 people 371 (19.8) 362 (97.6) 9 (2.4)
 ITN use
  No 1250 (66.9) 1226 (98.1) 24 (1.9) 0.18
  Yes 619 (33.1) 601 (97.1) 18 (2.9)
 Sprayed in past year
  No 723 (40.4) 710 (98.2) 13 (1.8) 0.36
  Yes 1065 (59.6) 1039 (97.6) 26 (2.4)
LAMP loop-mediated isothermal amplification, RDT rapid diagnostic test, ITN insecticide treated bed net, IRS indoor residual spraying
a Occupation was only assessed for participants over 15 years of age
b Herbalist, healer, bartender, land surveyor, soldier, headman
c Housing quality tertiles based on principle component analysis of wall type, roof type, eaves, and windows
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Risk factor assessment
The associations between different malaria risk factors 
and LAMP detectable malaria infection are shown in 
Table  1. There was no evidence of association between 
LAMP detectable malaria infection and gender. In both 
the unadjusted and adjusted analysis (Table  3), occu-
pational status was strongly associated with LAMP 
detectable infection. Compared to unemployed par-
ticipants, and adjusting for gender, age, socioeconomic 
status, and clustering at the health facility level, cattle 
herders (AOR 11.82, 95% CI 1.06–131.81) and agricul-
tural occupations (AOR 5.02, 95% CI 1.77–14.23) were 
significantly more likely to have a LAMP detectable 
malaria infection. There was no evidence of an associa-
tion between age group or household socioeconomic sta-
tus, and malaria infection.
Care-seeking behaviour
Of participants who reported fever in the previous 
2  weeks (n = 571), only 51.8% (95% CI 48.4% to 55.3%) 
reported seeking care (Table  4). Compared to LAMP-
negative subjects, LAMP-positive subjects were less 
likely to seek care (31.6% versus 52.5%), though the asso-
ciation did not reach statistical significance (p = 0.07). 
Among all individuals with recent fever and who sought 
care, almost all (91.9%) did so at a public health facility. 
The most common reason for seeking care was house-
hold proximity to a health facility (86.9%). The most com-
mon reasons for not seeking care for fever were lack of 
money for care or transportation (59.7%), and illness was 
not considered serious enough (15.2%).
Discussion
As a reservoir for persistent malaria transmission, sub-
patent malaria infections may pose a threat to coun-
tries like Namibia that are pursuing malaria elimination. 
Therefore, assessments of prevalence should not be lim-
ited to standard detection methods, such as microscopy 
and RDT. This study presents the results of the first large-
scale survey in Namibia to using molecular methods to 
measure the prevalence of malaria infections. According 
to the survey LAMP results, prevalence of infection in 
the Zambezi region of northeastern Namibia was low at 
2.2%, and almost half of prevalent infections were sub-
clinical and almost none were detectable by the standard 
point-of-care diagnostic RDT. Among the demographic 
and epidemiologic risk factors assessed, agricultural and 
cattle herding occupations were significantly associated 
with LAMP positivity.
Table 2 Diagnostic accuracy of RDT in total study population and those with and without fever in the past 2 weeks, using 
LAMP as gold standard (n = 1919)
Total (%, 95% CI) Fever in past 2 weeks (%, 95% CI) No fever 
in past 2 weeks (%, 
95% CI)
Sensitivity 2.3 (0.06–13.8) 0 (0.0–20.9) 4.2 (0.2–23.1)
Specificity 99.2 (98.7–99.5) 98.7 (97.3–99.4) 99.4 (98.7–99.7)
Positive predictive value 6.3 (0.33–32.3) 0 (0–43.9) 11.1 (0.6–49.3)
Negative predictive value 97.8 (97.0–98.4) 96.6 (94.7–97.9) 98.3 (97.4–98.9)
Table 3 Logistic regression analysis for  potential risk 
factors associated with LAMP detectable malaria infection 
(n = 1869)
OR odds ratio, AOR adjusted odds ratio
* Adjusted for gender, age, socioeconomic status, and clustering at the health 
facility level
a p-value = 0.01
b p-value = 0.04
c Herbalist, healer, bartender, land surveyor, soldier, headman
Potential risk factor 
for malaria infection
OR (95% CI) AOR* (95% CI)
Gender
 Female Ref
 Male 1.07 (0.58–1.95) 0.99 (0.42–2.30)
Age (years)
 < 15 Ref
 15–40 2.25 (1.11–4.55) 1.35 (0.50–3.65)
 > 40 1.81 (0.79–4.16) 0.79 (0.26–2.36)
Occupation
 Unemployed Ref
 Student 2.47 (0.65–9.31) 2.12 (0.25–17.94)
 Office/clerical/commercial/
professional
3.24 (0.37–28.76) 3.44 (0.21–57.40)
 Other manual labor 3.58 (0.68–18.92) 3.41 (0.11–107.45)
 Fishing 3.65 (0.41–32.48) 3.51 (0.65–19.01)
 Agricultural 4.55 (1.58–13.07) 5.02 (1.77–14.23)a
 Cattle herder 14.21 (2.97–68.12) 11.82 (1.06–131.81)b
 Otherc 15.93 (2.78–91.25) 11.26 (1.02–124.69)
Socioeconomic status quintile
 Lowest Ref
 Lower-middle 1.04 (0.39–2.81) 0.85 (0.39–1.89)
 Middle 0.97 (0.36–2.61) 0.70 (0.22–2.21)
 Upper-middle 0.96 (0.36–2.58) 0.71 (0.17–2.99)
 Highest 1.20 (0.47–3.08) 0.85 (0.26–2.75)
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The low diagnostic accuracy of RDTs in this setting 
is consistent with other studies that have found limited 
sensitivity of RDTs to detect low density infections with 
less than 100 to 200 parasites/μL [25]. In a meta-analy-
sis comparing diagnostics for the detection of asympto-
matic P. falciparum infection in over 30,000 individuals, 
mainly from low transmission settings, the prevalence 
of infection by RDT was 41% of the prevalence detected 
by molecular testing [3]. Similarly, in this study, the 0.8% 
prevalence of infection by RDT represented 36.4% of the 
2.2% prevalence by LAMP, and after excluding LAMP 
negatives (including 15 of the 16 RDT positives), sen-
sitivity of RDT using LAMP as gold standard was 2.4% 
(1 of 43 LAMP positives). Apart from the limited sensi-
tivity of RDT to low density infections, other potential 
explanations for the false negative RDT results were con-
sidered, such as limited sensitivity of the PAN/Pf RDT 
to detect non-falciparum infection [26]. However, all 
samples positive by genus-specific LAMP testing were 
positive by P. falciparum specific LAMP testing, and 
no non-falciparum infections were identified by PCR. 
Absence of HRP-2 antigen, the target for P. falciparum 
RDTs, has been reported in Africa and may be another 
contributing factor for false negative RDT results [27, 28]. 
Furthermore, 14 of the 16 RDT positives were LAMP or 
nPCR negative, potentially due to persistence of HRP-2 
antigen which has been reported to remain in the blood-
stream several weeks after successful treatment [29].
A key finding from this study was a higher risk of infec-
tion in individuals engaged in agricultural occupations 
and cattle herding. As it has been reported in other low 
transmission settings, outdoor occupations may increase 
exposure to mosquito bites [7, 30]. Furthermore, ITNs 
and IRS only provide protection from indoor biting. In 
low transmission settings, adult age has been frequently 
found to be associated with infection, presumably due 
to occupation and behavioural factors [7]. Results iden-
tified a trend of infection association with adult age, 
though the relationship was not statistically significant 
(Table 3). Male gender, bed net use, IRS coverage, lower 
Table 4 Characteristics of  subjects with  fever in  prior 2  weeks and  association between  care-seeking behaviour 
and infection
Care-seeking only assessed for those who reported fever in the past 2 weeks. Treatment source, days to seek treatment and reasons for seeking care only assessed for 
those who sought treatment. Reason for not seeking care only assessed for those who did not seek treatment
Sought care Total (%) LAMP negative (%) LAMP positive (%) p-value
n = 571 n = 552 n = 19
  No 275 (48.2) 262 (47.5) 13 (68.4) 0.07
  Yes 296 (51.8) 290 (52.5) 6 (31.6)
Care-seeking behaviour among subjects 
that sought care
Total (%) LAMP negative (%) LAMP positive (%) p-value
n = 296 n = 290 n = 6
 Treatment source
  Public 272 (91.9) 266 (91.7) 6 (100) 0.99
  Other 24 (8.1) 24 (8.3) 0 (0)
 Days to seek treatment
  ≤ 1 day 138 (46.6) 135 (46.6) 3 (50.0) 0.83
  > 1 day and ≤ 1 week 141 (47.6) 138 (47.6) 3 (50.0)
  > 1 week 17 (5.7) 17 (5.9) 0 (0)
 Reasons for seeking treatment
  Close to home 246 (83.1) 240 (82.8) 6 (100) 1.00
  Other 50 (16.9) 50 (17.2) 0 (0)
Reasons for not seeking treatment 
among subjects that did not seek care
Total (%) LAMP negative (%) LAMP positive (%) p-value
n = 275 n = 262 n = 13
  Lacked money for care or transportation 157 (57.1) 152 (58.0) 5 (38.5) 0.18
  Drugs not available 1 (0.4) 1 (0.4) 0 (0)
  Self-medication 13 (4.7) 11 (4.2) 2 (15.4)
  Long wait times at facility 3 (1.1) 3 (1.1) 0 (0)
  Distance/other transportation issue 17 (6.2) 17 (6.5) 0 (0)
  Illness not serious enough 40 (14.5) 36 (13.7) 4 (30.8)
  Other 44 (16.0) 42 (16.0) 2 (15.4)
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socioeconomic status, and international travel, were not 
associated with infection, in contrast to results from 
a recent case–control study from Engela, in northern 
Namibia [31]. Travel may not appear to be associated 
with infection in the current survey because such a small 
proportion of the sample reported international travel 
(0.9% in Zambezi versus 5% in Engela). Also, because the 
survey was conducted in April and only assessed travel in 
the prior 8  weeks, it did not capture travel details from 
the holiday season when travel peaks. Future work to 
better understand imported malaria should obtain more 
detailed travel history [32]. Finally, as geographical clus-
tering of infections was not observed, there was no clear 
spatial risk associated with malaria infection. This could 
be due to the small number of cases observed. Also, the 
study was not powered or designed to examine spatial 
clustering.
To examine coverage or availability of health care ser-
vices, health-seeking behaviour was assessed among sub-
jects who reported fever in the prior 2 weeks. There were 
no differences between LAMP positive and negative sub-
jects in terms of care-seeking at a private versus public 
facility, time between onset of symptoms and care-seek-
ing, or reasons for seeking or not seeking care. However, 
there was a trend in the association between LAMP posi-
tivity and not seeking care. Improved healthcare access 
could decrease the number of people in communities 
with malaria symptoms who do not seek care and conse-
quently increase the likelihood of transmitting infections 
to mosquitos. However, if these infections were subpat-
ent at time of presentation, there may be indication for 
more sensitive diagnostics in the clinical setting. Even 
with improved malaria care-seeking and improved point-
of-care diagnostics in the clinical setting, there remains 
the challenge of subclinical infections, which may require 
a community-based screening and treatment approach 
using more sensitive diagnostics, or presumptive treat-
ment [33].
There were some limitations to this study. First, cross-
sectional designs are suboptimal for identification of 
risk factors in low transmission settings due to the low 
number of cases and challenges in determining causal-
ity in the relationships between risk factors and preva-
lent infections. Indeed, the malaria incidence in 2015 
was historically low, largely due to a drought in southern 
Africa. Another drawback was that the classification of 
subclinical infection was based on self-reported history 
of fever in the prior 2  weeks, a subjective assessment 
which may not accurately reflect symptomatology. Fur-
ther, chronic subpatent infection can persist for months 
and the fever assessment of just 2 weeks was limited [34]. 
Cohort studies with regular measurement of temperature 
and more detailed assessment of symptoms would be a 
stronger study design, but impractical in this low trans-
mission setting due to the low prevalence of infection. 
Finally, very low-density infections may have been missed 
because high blood volumes were not collected and 
an ultrasensitive molecular detection method was not 
used [35]. There is a growing body of evidence suggest-
ing near equivalence of LAMP to nPCR [20, 36–38] and 
the use of a higher volume of template DNA for LAMP 
compared to nPCR likely helped to improve the sensitiv-
ity of LAMP. However, to better elucidate the extent of 
low-density infection and the numerical distribution of 
parasite density, future studies could utilize more sensi-
tive detection methods.
This study is the first large-scale malaria cross-sec-
tional survey in Namibia using molecular testing and 
highlighted the importance of subpatent infections in 
this low transmission setting [11]. Fever history and 
standard RDTs do not appear useful to address this bur-
den. Achievement of malaria elimination may require 
active case detection using more sensitive point-of-care 
diagnostics or presumptive treatment (e.g. mass drug 
administration). Agricultural occupations and cat-
tle herding were associated with a higher risk of infec-
tion and achievement of malaria elimination will likely 
require intervention strategies that target this high-risk 
population.
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